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Abstract
In a recent article, elevated cerebrospinal fluid pressure (CSFP) consistent with very early normal
pressure hydrocephalus (NPH), was found in a small subset of Alzheimer's disease (AD) patients
(possible AD-NPH hybrids) enrolled in a clinical trial for chronic low-flow cerebrospinal fluid
drainage. Also in the same study, was another interesting finding that merits further discussion: a
substantial proportion of AD patients had very low CSFP. Based on the characteristics of these
subjects, we hypothesize that more advanced AD may be associated with a decrease in CSFP.
Reduced CSFP among a group of AD patients could provide a clue towards a better understanding
of the high rate of comorbidity reported between AD and glaucoma since it has been shown that
mean CSFP is lower in subjects with primary open-angle glaucoma. This could result in an
abnormally high trans-lamina cribrosa pressure difference and lead to glaucomatous damage.
Introduction
In a recent article published in Cerebrospinal Fluid Research,
Silverberg et al. reported elevated cerebrospinal fluid pres-
sure (CSFP), consistent with very early normal pressure
hydrocephalus (NPH), in a small subset of Alzheimer's
disease (AD) patients enrolled in a clinical trial of chronic
low-flow cerebrospinal fluid (CSF) drainage [1]. This AD-
elevated CSFP group provided further support for the
existence of an AD-NPH hybrid and CSF circulatory fail-
ure. However, the same study reported another interesting
finding that we believe merits further discussion, in that a
substantial proportion of AD patients had very low CSFP.
In the present article, we briefly summarize supportive
evidence from these observations that suggest that more
advanced AD may be associated with a decrease in CSFP.
Interestingly, the finding of a high occurrence of reduced
CSFP among patients with AD could shed new light on
the link between AD and glaucoma [2,3].
Discussion
An article entitled "Elevated cerebrospinal fluid pressure
in patients with Alzheimer's disease", reported on CSFP in
patients with AD [1]. This was a clinical trial to evaluate
the safety and efficacy of low-flow shunting in subjects
that met strict National Institutes of Neurological and
Communicative Diseases and Stroke-Alzheimer's Disease
and Related Disorders Association criteria for probable
AD. The therapeutic objective guiding low-flow ventricu-
loperitoneal shunting as a treatment for AD was to
improve safely the CSF turnover and clearance of meta-
bolic by-products, such as β-amyloid and tau, from the
brain. Subjects were carefully screened to exclude those
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with clinical, radiographic, or CSFP signs of NPH. As a
final exclusion prior to shunt implantation, CSFP was
measured supine under general anesthesia via the
implanted ventricular catheter [1]. Normally, CSFP ranges
from 5 - 15 mmHg (or 68 - 204 mmH2O) and age is not
known to affect CSFP in adults [4]. During the initial
implantation procedure, seven of the 181 subjects (3.9%)
with no clinical or radiographic signs of NPH had an
opening CSFP >200 mmH2O [1]. These subjects were
withdrawn from the remainder of the study, because of
probable associated early NPH. For this AD-elevated CSFP
group, the mean CSFP was 249 ± 20 mmH2O. AD patients
with elevated CSFP were significantly younger (67 ± 6
years vs. 74 ± 6) and significantly less demented on the
Mattis Dementia Rating Scale (MDRS) (118 ± 6 vs. 106 ±
17) than those without elevated CSFP [1]. The AD group
without elevated CSFP consisted of 174 subjects (the
remaining 96.1%). Mean opening CSFP in this group was
103 ± 47 mmH2O, which was statistically significantly
lower when compared to the AD-elevated CSFP group and
a somewhat younger non-demented control group of sub-
jects with Parkinson's disease (140 ± 60 mmH2O) [1,5].
The distribution of CSFP in all AD subjects is shown in
Figure 1. Remarkably, the frequency histogram of the
CSFP distribution shows a substantial proportion of AD
patients with very low CSFP. Indeed, it could be argued
that there were two subgroups of AD patients within the
group without elevated CSFP: those with nearly normal
CSFP and those with much lower CSFP (G. Silverberg, per-
sonal communication, 2008). Forty-two of the 174 sub-
jects (24.1%) had a CSFP lower than the normal range [1].
This is a much higher proportion than one would expect
from a normal population. An unexpected finding of this
study was the relatively high (>30%) proportion of sub-
jects with moderate to severe dementia as measured by
MDRS total scores below 100, despite inclusion-exclusion
criteria designed to capture subjects with mild to moder-
ate dementia (Mini-Mental State Examination score
between 15 and 24, inclusive) [1,6]. Although not specif-
ically investigated in this study, cerebral atrophy associ-
ated with moderate to severe AD could be hypothesised to
be associated with lower CSFP (G. Silverberg, personal
communication, 2008). In the present article, we focus on
the AD group without elevated CSFP. To the best of our
knowledge, there is no previous study reporting a high
occurrence of very low CSFP among patients with AD.
Based on the characteristics (older and more demented on
the MDRS) of the AD patients without elevated CSFP, we
hypothesize that more advanced AD may be associated
with a decrease in CSFP.
Frequency histogram showing the distribution of cerebrospinal fluid pressure (CSFP) in all subjects with Alzheimer's disease  (AD) Figure 1
Frequency histogram showing the distribution of cerebrospinal fluid pressure (CSFP) in all subjects with 
Alzheimer's disease (AD). Reproduced from Silverberg et al. [1] with permission.Cerebrospinal Fluid Research 2009, 6:14 http://www.cerebrospinalfluidresearch.com/content/6/1/14
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The finding of a high occurrence of reduced CSFP among
AD patients is of major importance because it may pro-
vide a better understanding of the high rate of comorbid-
ity reported between AD and glaucoma [2,3]. In a nursing
home-based study in Germany, the prevalences of glau-
coma (as defined by characteristic optic nerve or visual
field changes) were reported to be 25.9% in patients with
AD and 5.2% in controls [3]. In another study, Tamura et
al. found that the prevalence of open-angle glaucoma
(OAG) in Japanese patients with AD was 23.8%, which
was significantly higher than that of the control subjects
(9.9%) [2]. There was no significant difference between
intraocular pressures (IOPs) in AD patients with OAG and
without OAG, and almost all AD patients with OAG
showed normal tension. Furthermore, in a retrospective
case-control study, Berdahl et al. reported the intriguing
new observation that mean CSFP was 33% lower in sub-
jects with primary open-angle glaucoma (POAG) (9.2
mmHg) compared with that of nonglaucomatous con-
trols (13.0 mmHg; P < 0.00005) [4]. The authors noted
that their observation supports the concept that an abnor-
mally high trans-lamina cribrosa pressure difference plays
an important role in glaucomatous optic nerve damage,
whether the result of elevated IOP, reduced CSFP or both.
Considering the above data, it seems reasonable to specu-
late that there may be a causal relationship between AD
and glaucoma that may be explained by low CSFP in
patients with AD. This obviously needs to be confirmed
by future research.
It should be stressed that other factors might also explain
the link between AD and glaucoma. For example, Tamura
et al. evaluated the APOE ε4 allele as a common genetic
risk factor for AD and OAG [2]. However, the percentage
of AD patients with OAG who carried an APOE ε4 allele
was not significantly different to that of AD patients with-
out OAG, suggesting that APOE ε4 polymorphism may
not be a common risk factor predisposing to both disor-
ders [2]. Recently, Helicobacter pylori infection has also
been suggested to be involved in the pathogenesis of both
AD and glaucoma [7]. To investigate whether primary
open-angle glaucoma is associated with increased risk of
developing AD, Kessing et al. carried out a nationwide case
register study comparing the rate of subsequent AD for
patients with POAG (including normal tension glau-
coma) with the rate for patients with primary angle-clo-
sure glaucoma (PACG), cataract, and osteoarthritis (OA)
and with the rate for the general population [8]. All
patients included in the study were identified at hospital
admission or outpatient contact during the period 1977
to 2001 in Denmark. However, the hypothesis that
patients with POAG have increased risk of developing AD
was not supported by the results [8].
Conclusion
In conclusion, we have summarized supportive evidence
from the observations of Silverberg et al. that suggest that
more advanced AD may be associated with a decrease in
CSFP. The finding of a 24.1% occurrence of reduced CSFP
among 174 patients with AD could be linked to the high
rate of comorbidity between AD and glaucoma, since it
has been shown that mean CSFP is lower in subjects with
POAG. This could result in an abnormally high trans-lam-
ina cribrosa pressure difference and lead to glaucomatous
damage.
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